BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19453368)

  • 1. Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.
    Skorupski KA; Rodriguez CO; Krick EL; Clifford CA; Ward R; Kent MS
    Vet Comp Oncol; 2009 Jun; 7(2):139-44. PubMed ID: 19453368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
    J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.
    Mason SL; Finotello R; Blackwood L
    Vet Comp Oncol; 2018 Mar; 16(1):E30-E37. PubMed ID: 28621004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma.
    Rassnick KM; Moore AS; Russell DS; Northrup NC; Kristal O; Bailey DB; Flory AB; Kiselow MA; Intile JL
    J Vet Intern Med; 2010; 24(6):1528-31. PubMed ID: 21155191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma.
    Klahn SL; Kitchell BE; Dervisis NG
    J Am Vet Med Assoc; 2011 Jul; 239(1):90-6. PubMed ID: 21718201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
    Cannon C; Borgatti A; Henson M; Husbands B
    J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for dogs with lymph node metastasis from histiocytic sarcomas.
    Moore AS; Taylor DP; Reppas G; Frimberger AE
    Aust Vet J; 2017 Jan; 95(1-2):37-40. PubMed ID: 28124419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCNU for the treatment of dogs with histiocytic sarcoma.
    Skorupski KA; Clifford CA; Paoloni MC; Lara-Garcia A; Barber L; Kent MS; LeBlanc AK; Sabhlok A; Mauldin EA; Shofer FS; Couto CG; Sørenmo KU
    J Vet Intern Med; 2007; 21(1):121-6. PubMed ID: 17338159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers.
    Elliott J
    Aust Vet J; 2018 Dec; 96(12):502-507. PubMed ID: 30478839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors.
    Hosoya K; Kisseberth WC; Alvarez FJ; Lara-Garcia A; Beamer G; Stromberg PC; Couto CG
    J Am Anim Hosp Assoc; 2009; 45(1):14-8. PubMed ID: 19122059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimustine Treatment of 11 Cases of Canine Histiocytic Sarcoma.
    Tani H; Kurita S; Miyamoto R; Sawada H; Fujiwara-Igarashi A; Michishita M; Azakami D; Hasegawa D; Tamura K; Bonkobara M
    J Am Anim Hosp Assoc; 2020; 56(3):146. PubMed ID: 32182105
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome in dogs with curative-intent treatment of localized primary pulmonary histiocytic sarcoma.
    Murray CA; Willcox JL; De Mello Souza CH; Husbands B; Cook MR; Clifford C; Leeper H; Pellin M; Richardson D; Herrera CL; Krick E; McMillan S; Al-Nadaf S; Skorupski KA
    Vet Comp Oncol; 2022 Jun; 20(2):458-464. PubMed ID: 34878710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy.
    Latifi M; Tuohy JL; Coutermarsh-Ott SL; Klahn SL; Leeper H; Dervisis N
    J Vet Intern Med; 2020 Nov; 34(6):2645-2650. PubMed ID: 32986268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs.
    Kezer KA; Barber LG; Jennings SH
    Vet Comp Oncol; 2018 Mar; 16(1):77-80. PubMed ID: 28419676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of carboplatin in multi-modality treatment of canine tonsillar squamous cell carcinoma--a case series of five dogs.
    Murphy S; Hayes A; Adams V; Maglennon G; Neath P; Ladlow J; Brearley MJ
    J Small Anim Pract; 2006 Apr; 47(4):216-20. PubMed ID: 16573766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
    J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary pulmonary histiocytic sarcoma in dogs: A retrospective analysis of 37 cases (2000-2015).
    Marlowe KW; Robat CS; Clarke DM; Taylor A; Touret M; Husbands BD; Vail DM
    Vet Comp Oncol; 2018 Dec; 16(4):658-663. PubMed ID: 30246460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
    Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
    J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases.
    Cooper M; Tsai X; Bennett P
    Vet Comp Oncol; 2009 Sep; 7(3):196-206. PubMed ID: 19691648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.